ATTD: Advanced Technologies and Treatments for Diabetes

ATTD on UNLOK
  • 0.0 (0)
  • LIFE SCIENCES

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.

  1. The optimal Diabetes Technology educational pathway for Nurses & Educators

    NOV 4

    The optimal Diabetes Technology educational pathway for Nurses & Educators

    How can diabetes educators be supported in the fast-moving world of diabetes technology? In the first episode of ATTD Tech Connect, host Julie Taplin discusses the need for an educational pathway for diabetes educators when training PwD on the MiniMed™ 780G system with Geraldine Gallen. They discuss: Why the pathway is needed The four key components of the pathway The barriers to providing diabetes educator training Implementing the pathway at King’s College Hospital Geraldine Gallen is a Type 1 Service Lead and Diabetes Nurse Consultant at Kings College Hospital, London. She is UK​ and Vice Chair of the Association of British Clinical Diabetologists (ABCD) – Diabetes Technology Network (DTN), UK​.  This series is sponsored by Medtronic Diabetes. Explore further resources: ATTD Education Portal. Register now to access exclusive content and stay ahead in the field. Minimed Medtronic Academy and WePartner Online Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    14 min
  2. Coming Soon: ATTD Tech Connect

    TRAILER

    Coming Soon: ATTD Tech Connect

    Diabetes technology is evolving fast. In ATTD Tech Connect, we show how it can help healthcare professionals — nurses, educators, and dieticians — improve therapy and daily life for people living with diabetes. In this new series sponsored by Medtronic Diabetes, you’ll learn from diverse clinical experience and evidence-based guidance from leaders in diabetes care, tailored for those who support patients every day. Hosted by Julie Taplin, Dietician and Medtronic Diabetes Education Specialist, the series will explore practical strategies to reduce burden, support meal planning and exercise, and optimize outcomes in real-world care. Make sure you’re subscribed to the ATTD Podcast feed today. Explore further resources: ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Minimed Medtronic Academy and WePartner Online

    1 min
  3. The future of CGM in maternal health

    OCT 7

    The future of CGM in maternal health

    In the final episode of our series on CGM technology, Ginger Vieira explores the future directions for CGM in high-risk pregnancy care with Dr Claire Meek. They discuss: High-Risk Pregnancies and Current Gaps in Care Challenges in Type 2 Diabetes Research Impact of CGM Technology During Pregnancy Pre-Pregnancy and Pregnancy Care for Type 2 Diabetes Third Trimester and Delivery Considerations Early Adoption of Hybrid Closed Loops Dr Claire Meek is a Professor of Chemical Pathology & Diabetes in Pregnancy at the University of Leicester in the UK. She’s also an Honorary Consultant Chemical Pathologist & Metabolic Physician at the Addenbrooke’s Hospital. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    21 min
  4. Postpartum CGM management and diabetes risk

    SEP 30

    Postpartum CGM management and diabetes risk

    In this episode, Ginger Vieira looks at postpartum CGM management, diabetes risk, and what clinicians can do to support women during this significant life event. She is joined by Dr Grenye O’Malley. They discuss: How glucose patterns and insulin needs change postpartum GDM as a spectrum to Type 2 diabetes CGM use for early detection of type 2 diabetes after GDM Strategies for transitioning from intensive pregnancy care to postpartum follow-up Grenye O'Malley is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Diseases at the Icahn School of Medicine at Mount Sinai. She has research interests in the use of diabetes technologies focusing on health disparities and management of diabetes during pregnancy. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    23 min
  5. Common pitfalls and troubleshooting CGM use during pregnancy

    SEP 23

    Common pitfalls and troubleshooting CGM use during pregnancy

    In this episode, Ginger Vieira explores the common pitfalls of CGM use in pregnancy with Dr Sarit Polsky. They discuss: Common barriers to successful CGM use in pregnancy, including skin issues and alarm fatiguePractical troubleshooting strategies for clinicians and patientsThe role of education and support in overcoming CGM-related challenges Sarit Polsky is an Associate Professor of Medicine and Pediatrics at the University of Colorado, where she is the Director of the Pregnancy and Women’s Health Clinic. She is the Research Director of the Adult Clinic at the Barbara Davis Center for Diabetes and the co-Director of the American College of Diabetology Annual Conference. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    18 min
  6. CGM research and trends in pregnancy

    SEP 16

    CGM research and trends in pregnancy

    In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy. She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy. They discuss: How CGM improves maternal and neonatal outcomes Key clinical trials including the CONCEPTT trial Evolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM) Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    16 min
  7. The Future of AI-Driven CGM in Diabetes & Metabolic Health

    SEP 9

    The Future of AI-Driven CGM in Diabetes & Metabolic Health

    In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare. They discuss: How AI and CGM technology is transforming diabetes and metabolic health management AI identification of diabetes subtypes and personalised interventions Impact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellness Potential of AI-driven tools for early intervention and improved health outcomes Dr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    23 min
  8. AI-Driven CGM & Personalized Medicine

    SEP 2

    AI-Driven CGM & Personalized Medicine

    In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike. To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra. They cover: The Role of AI in Continuous Glucose Monitoring Challenges and Potential of AI in Diabetes Management AI and CGM for Young People with Diabetes Potential for AI to instigate behaviour change Dr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    19 min
See All (42)

Trailers

About

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.

Information

You Might Also Like